Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New AI Technology Pinpoints Negative Symptoms in Cancer Patients

By HospiMedica International staff writers
Posted on 08 Jan 2019
Researchers from the University of Surrey (England, UK) and the University of California {(UCSF) San Francisco, CA, USA} have developed a new artificial intelligence (AI) tool, which can predict symptoms and their severity throughout the course of a cancer patient's treatment.

In what is believed to be the first study of its kind, the researchers created two machine learning models which are both able to accurately predict the severity of three common symptoms faced by cancer patients - depression, anxiety and sleep disturbance. More...
All these three symptoms are associated with severe reduction in the quality of life of cancer patients.

The researchers analyzed the existing data of the symptoms experienced by cancer patients during the course of their computed tomography X-ray treatment. The team used different time periods during this data to test whether the machine learning algorithms were able to accurately predict when and if the symptoms surfaced. The researchers found that the actual reported symptoms were very close to those predicted by the machine-learning methods.

"These exciting results show that there is an opportunity for machine learning techniques to make a real difference in the lives of people living with cancer. They can help clinicians identify high-risk patients, help and support their symptom experience and preemptively plan a way to manage those symptoms and improve quality of life," said Payam Barnaghi, Professor of Machine Intelligence at the University of Surrey.

"I am very excited to see how machine learning and AI can be used to create solutions that have a positive impact on the quality of life and well-being of patients," said Nikos Papachristou, who worked on designing the machine learning algorithms for the project.

Related Links:
University of Surrey
University of California San Francisco


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A smartphone application displays a glucose concentration that was measured using the new sensor (Photo courtesy of Chuchu Chen and Yonghao Fu)

Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems

Monitoring blood glucose is essential for people with diabetes to prevent complications and maintain long-term health. Current continuous glucose monitoring systems require needles inserted under the skin,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.